Orphan Medical Xyrem FDA Study Request Could Delay Launch Until Mid-2002
Orphan Medical's launch for its narcoleptic cataplexy treatment Xyrem could be delayed until mid-2002 by an FDA request for a study of respiratory-compromised patients.
Orphan Medical's launch for its narcoleptic cataplexy treatment Xyrem could be delayed until mid-2002 by an FDA request for a study of respiratory-compromised patients.